The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that a migraine medication commercial featuring Serena Williams is “misleading.
AbbVie makes you the star of its new acute migraine drug ad with tennis phenom Serena Williams. Make that “U”—as in Ubrelvy. The latest TV ad in Ubrelvy’s “Anytime, Anywhere” series shows three ...
The FDA has faulted AbbVie’s promotion of the migraine drug Ubrelvy, calling the company out for an ad featuring Serena Williams that went out of bounds with claims about how quickly the product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results